Video

Dr. Turaga Discusses Current Surgical Setting of Sarcoma

Kiran Turaga, MD, MPH, surgical oncologist, University of Chicago Cancer Center, discusses the current surgical setting of sarcoma.

Kiran Turaga, MD, MPH, surgical oncologist, University of Chicago Cancer Center, discusses the current surgical setting of sarcoma.

Although surgical resection remains standard for patients with retroperitoneal sarcomas, Turaga says, the concept of compartmental resection is being explored once again.

Recently, adjuvant systemic chemotherapy was explored in patients with sarcomas, but the data was not strong for sarcomas as a group, says Turaga. There does seem to be benefits in some subgroups, such as leiomyosarcoma.

Additionally, the recent investigation into the use of multi-receptor TKIs, such as pazopanib (Votrient), is interesting, Turaga says.

Related Videos
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Tanios Bekaii-Saab, MD, FACP
Moritz Fürstenau, MD
Jun Gong, MD
Thierry Facon, MD
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Marshall Posner, MD
Renee Saliby, MD, MSc